E. David Crawford, MD, Editor-in-Chief
LEARNING CENTERS
LATEST CONTENT
John P. Mulhall, MD, discusses the significant sexual and non-sexual adverse events of low testosterone resulting from using androgen deprivation therapy (ADT) to treat men with prostate cancer. He emphasizes the need for physicians to counsel patients on long-term expectations and to obtain fully-informed consent prior to the initiation of this therapy.
Gerald L. Andriole, Jr., MD, reviews the history of conventional transrectal ultrasound (TRUS) guided biopsy and the limitations of this technique that remain in the modern era. He then discusses current and emerging efforts to improve image guided prostate biopsies.
Fernando J. Kim, MD, MBA, FACS, discusses internal physician factors and external factors in the current medical field that can put careers and patient safety at risk. He then reviews ways in which systems thinking and professionalism can optimize outcomes in urology practices.
Chemotherapy: An Infusion Nurse’s Experience This interview, "Chemotherapy: An Infusion Nurse’s Experience," is provided by Grand Rounds in Urology's content partner, Prostatepedia. Catherine Guider is an infusion nurse with Kaiser Permanente in Sacramento, CA. She...
Arthur L. Burnett II, MD, MBA, presents penile allotransplantation as an emerging alternative to autogenous reconstruction. He discusses the benefits for military trauma patients in particular, and the importance of considering potential complications as well as improved quality of life.
Michael J. Zelefsky, MD, argues that combining stereotactic body radiation therapy (SBRT) with low-dose rate brachytherapy can help to reduce the morbidities of combined-modality radiotherapy. He also emphasizes the need to address the issue of toxicity with careful patient selection, treatment planning, and adherence to tight dose constraints.
Nelson N. Stone, MD, explains that many studies show benefits from combination external beam radiation therapy (EBRT) and brachytherapy in high-risk prostate cancer patients. He then discusses potential reasons for these benefits and the impact of brachytherapy dosage in patient outcomes.
